RMD.AU Resmed Inc

Healthcare Health Care Equipment & Supplies Australian Securities Exchange
35.51 AUD
Close of Nov 1, 2026
25.42 39.61
Market cap
AUD 49.9B
P/E
22.3x
P/B
5.92x
ROE
28.3%
Dividend yield
10.54%
Fundamental score
3.8/5

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.

Is RMD.AU undervalued?

Graham number
Price35.51
Graham value14.64
Premium142.5%

RMD.AU trades 142.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Resmed Inc fundamental analysis

16 of 22 checks passed

ROE 2/2

High return on equity (28.3%), above 20%.

ROA 1/1

Return on assets (20.5%) is above the industry median (-35.3%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (12.1%) is not above the 5-year average (26.9% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (12.1%) is below the industry median (24.9%).

Revenue Growth 2/2

Revenue grew 11.0% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (10.3%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

No interest expense reported.

PE vs Market 0/1

PE (22.3x) is above the market median (15.0x).

PE vs Industry 1/1

PE (22.3x) is below the industry median (36.4x).

PBV 0/1

Price to book (5.9x) is above the industry median (4.0x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 132.3, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.83, growth is cheap.

Dividend Yield 0/2

Dividend yield (1.0%) is in the bottom 25% of dividend payers in the market.

Dividend Stability 2/2

Dividends paid without a cut of more than 10% for 11 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 23.0%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Resmed Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Resmed Inc

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl…

Full company profile